We are live on ! Find out more
AIIC

AJU IB Investment Company Portfolio holdings

AUM $30.5M
1-Year Est. Return 128.96%
This Fund
S&P 500
This Quarter Est. Return
+26.06%
1 Year Est. Return
+128.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
+$23.2M
Cap. Flow
-$281K
Cap. Flow %
-0.24%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CARM
Carisma Therapeutics
CARM
+$281K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$86M 74.71%
1,047,557
– –
KYMR icon
2
Kymera Therapeutics
KYMR
$8.94B
$25.9M 22.47%
457,059
– –
SEER icon
3
Seer Inc
SEER
$120M
$1.8M 1.57%
816,375
– –
XLO icon
4
Xilio Therapeutics
XLO
$60.3M
$596K 0.52%
47,696
– –
RLYB icon
5
Rallybio
RLYB
$85.8M
$377K 0.33%
94,335
– –
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
$321K 0.28%
12,437
– –
STRO icon
7
Sutro Biopharma
STRO
$421M
$153K 0.13%
17,500
– –
CARM
8
DELISTED
Carisma Therapeutics
CARM
– –
-718,332
Closed -$281K

Similar funds

LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
OGC
One68 Global Capital New York $30.9M AUM
AC
ASB Consultores Aventura, Florida $30.1M AUM 22.96% 1-Year Est. Return
PL
Protective Life Birmingham, Alabama $30.1M AUM 0.65% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $29M AUM 1.79% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return

AJU IB Investment Company's Q3 2025 Portfolio in Review

As of Q3 2025, AJU IB Investment Company held 8 positions worth $115M, up 25% from $91.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

AJU IB Investment Company's Q3 2025 filing shows 1 closed position. The largest sale was Carisma Therapeutics, an estimated $281K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AJU IB Investment Company fully exited Carisma Therapeutics in Q3 2025, selling an estimated $281K.
  • AJU IB Investment Company's ten largest holdings make up 100% of its $115M portfolio in Q3 2025.
  • AJU IB Investment Company opened 0 new positions and closed 1 in Q3 2025.
  • AJU IB Investment Company's portfolio value rose 25% quarter-over-quarter to $115M.

Based on AJU IB Investment Company's 13F filing for Q3 2025, filed 6 Nov 2025.